Kathmere Capital Management, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1794543
WAYNE, PA
Position in TEVA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$326,603
New position
Shares Held
9,640
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#449
of 671 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kathmere Capital Management, LLC holds $1,705,003 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,932 | $641,853 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
9,640 | $326,603 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
13,597 | $217,959 | |
| 4 | VTRS |
Viatris Inc
|
12,852 | $204,089 | |
| 5 | HLN |
Haleon plc
|
17,050 | $159,076 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
31,526 | $155,423 |
All Filings in TEVA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,603 | 9,640 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||